RAGHU K G | Pharmacology | Best Researcher Award

Posted on by ScienceFather

Dr. RAGHU K G | Pharmacology | Best Researcher Award

JUBILEE MISSION MEDICAL COLLEGE AND RESEARCH INSTITUTE,THRISSUR-India

Author Profile

Early Academic Pursuits 📚

Dr. K.G. Raghu’s journey in scientific research began with a strong academic foundation in the life sciences. He completed his Bachelor’s degree in Zoology, Botany, and Chemistry from Calicut University in 1983, achieving first-class honors. His passion for understanding biological systems led him to pursue a Master’s degree in Zoology from the same university, graduating in 1985 with first-class distinction.Dr. Raghu’s pursuit of knowledge continued with a Ph.D. from Saurashtra University, where his research focused on the effects of organomercurials pollution on the biochemical changes in the central nervous system of rats. His dissertation, titled “Effect of Organomercurials Pollution in Animals: Evaluation of Biochemical Changes in the Central Nervous System of Rat with Methylmercury and Chelators,” was completed under the supervision of Prof. P. P. Sood. This early work laid a solid groundwork for his future research in neurotoxicology and pharmacology.Following his Ph.D., Dr. Raghu undertook post-doctoral research at the Department of Biotechnology, Cochin University of Science & Technology. His research, supervised by Dr. C.S. Paulose, focused on neurotransmitter-receptor functions in mercury poisoning and the effects of chitosan.

Professional Endeavors 🔬

Dr. Raghu’s professional career is marked by significant contributions to the field of pharmacology and drug development, particularly in cardiovascular disease (CVD) and metabolic syndrome. His career began at the CSIR Central Drug Research Institute, Lucknow, where he served in various capacities from Scientist B to Senior Scientist between 1995 and 2008. His work focused on drug development for cardiovascular diseases and safety pharmacology, which helped advance therapeutic approaches in this critical area.In 2008, Dr. Raghu joined the CSIR-National Institute for Interdisciplinary Science & Technology (NIIST), Trivandrum, where he made remarkable contributions as a Senior Scientist, Principal Scientist, and eventually Senior Principal Scientist. His research during this period centered on the basic biology of metabolic syndromes and bioactives. He led pioneering studies on the development of leads for metabolic syndrome and explored bioactive compounds with therapeutic potential.In 2021, Dr. Raghu retired as Chief Scientist from NIIST but continued his impactful work as an Honorary Scientist at the Jubilee Mission Medical College & Research Institute, Trichur, Kerala. His research continues to address the fundamental biology of metabolic syndromes, further demonstrating his dedication to advancing medical science.

Contributions and Research Focus 🧬

Dr. Raghu’s research has had a profound impact on the understanding and treatment of metabolic syndromes and cardiovascular diseases. His studies have explored the biochemical mechanisms underlying these conditions and developed potential therapeutic leads. Notable contributions include:

  • Drug Development for Cardiovascular Diseases: Dr. Raghu’s early work involved developing and testing new drugs for cardiovascular conditions, focusing on safety pharmacology.
  • Metabolic Syndrome Research: His later research at NIIST was groundbreaking in exploring the basic biology of metabolic syndromes and developing bioactive compounds to combat these disorders. His work on compounds from natural sources has been particularly influential in identifying potential new treatments.

Dr. Raghu has also been instrumental in supervising Ph.D. and post-doctoral research, guiding several students and researchers in their scientific careers. His mentorship has led to significant advancements in the understanding of oxidative stress, cardiac hypertrophy, and metabolic syndrome.

Accolades and Recognition 🏆

Dr. Raghu’s contributions have been widely recognized in the scientific community. His work has not only advanced the field of pharmacology but has also earned him a place among the leading researchers in metabolic syndrome and cardiovascular diseases. He is a Fellow of the Indian Academy of Biomedical Sciences and the Kerala Academy of Sciences, highlighting his prominence and influence in the field.

Impact and Influence 🌍

Dr. Raghu’s research has had a lasting impact on the scientific understanding of cardiovascular and metabolic diseases. His innovative approaches and discoveries have paved the way for new therapeutic strategies and drug developments. His role as a mentor and guide to numerous researchers has further amplified his influence, fostering a new generation of scientists dedicated to advancing medical research.

Legacy and Future Contributions 🔮

As Dr. Raghu continues his work as an Honorary Scientist at the Jubilee Mission Medical College & Research Institute, his legacy is characterized by a commitment to advancing scientific knowledge and improving human health. His ongoing research aims to unravel further complexities of metabolic syndromes and develop effective interventions.Dr. Raghu’s career serves as an inspiring example of how dedication to research and mentoring can lead to significant advancements in science and medicine. His work not only contributes to the current understanding of critical health issues but also sets the stage for future breakthroughs in the field.

Citations

A total of 2610 citations for his publications, demonstrating the impact and recognition of his research within the academic community.

  • Citations         2610
  • h-index           102
  • i10-index        31

Notable Publications

  • Title: Joubert syndrome causing mutation in C2 domain of CC2D2A affects structural integrity of cilia and cellular signaling molecules
    Authors: Jayarajan, R.O., Chakraborty, S., Raghu, K.G., Purushothaman, J., Veleri, S.
    Journal: Experimental Brain Research
    Year: 2024.
  • Title: Corrosion and in vitro characteristics of cerium phosphate based chemical conversion coating on AZ31 magnesium alloy
    Authors: Jayaraj, J., Kumar, S.A., Srinivasan, A., Arunchandran, C., Rajinikanth, V.
    Journal: Applied Surface Science
    Year: 2024.
  • Title: A clinically feasible diagnostic spectro-histology built on SERS-nanotags for multiplex detection and grading of breast cancer biomarkers
    Authors: Murali, V.P., Karunakaran, V., Murali, M., Sujathan, K., Maiti, K.K.
    Journal: Biosensors and Bioelectronics
    Year: 2023.
  • Title: Vanillic acid mitigates hyperinsulinemia induced ER stress mediated altered calcium homeostasis, MAMs distortion and surplus lipogenesis in HepG2 cells
    Authors: Mohan, S., Nair, A., Poornima, M.S., Raghu, K.G.
    Journal: Chemico-Biological Interactions
    Year: 2023.
  • Title: In vitro and in vivo anti-inflammatory and anti-arthritic effect of Tinospora cordifolia via modulation of JAK/STAT pathway
    Authors: George, G., Shyni, G.L., Mohan, S., Rajankutty, K., Raghu, K.G.
    Journal: Inflammopharmacology
    Year: 2023.

Archana Kapoor | Pharmaceutical | Best Researcher Award

Posted on by ScienceFather

Prof. Archana Kapoor | Pharmaceutical | Best Researcher Award

Guru Jambheshwar University of Science & Technology-India

Author Profile

Early Academic Pursuits 📚

Born on October 25, 1978, Archana Kapoor embarked on her academic journey with a passion for pharmaceutical sciences. She pursued her undergraduate and postgraduate studies in Pharmaceutical Chemistry at Punjab University, Chandigarh, one of India’s premier institutions. Earning her post-graduation in 2003, she honed her expertise in drug discovery, medicinal chemistry, and pharmacokinetics. Her strong foundation in chemistry and pharmaceutical sciences earned her a GATE scholarship, a prestigious recognition of her academic excellence. Archana further enhanced her academic credentials by completing her Doctorate in Pharmaceutical Sciences from Guru Jambheshwar University of Science & Technology in 2016, marking a significant milestone in her pursuit of scientific knowledge and innovation.

Professional Endeavors 👩‍🔬

With almost 18 years of experience, Archana Kapoor’s career reflects her dedication to bridging the gap between academic research and industrial application. She commenced her professional journey in 2006 by joining Dr. Reddy’s Laboratories, Hyderabad, as a Scientist in the Discovery Chemistry section. During her tenure at Dr. Reddy’s, she gained invaluable experience in drug metabolism, pharmacokinetics, and advanced bioanalytical techniques such as HPLC and LC-MS/MS. Her work in the AMPK kinase project focused on developing lead series for Type-II Diabetes, contributing to the global efforts in combating this widespread condition.In 2016, Archana transitioned into academia, where she now serves as a Professor in the Department of Pharmaceutical Sciences at Guru Jambheshwar University of Science & Technology. Here, she plays a pivotal role in teaching, mentoring students, and spearheading research initiatives. Her ability to integrate real-world experience with academic learning has made her a respected figure among her peers and students alike.

Contributions and Research Focus 🔬

Archana Kapoor’s research portfolio is a testament to her deep commitment to advancing pharmaceutical sciences. Her work spans drug discovery, molecular docking, and pharmacokinetic analysis. One of her most significant contributions is her research on “5-Nitro-N-phenyl-3-(phenylamino)-1H-indazole-1-carboxamide Derivatives as Potential Anticancer Agents.” This study integrates chemical synthesis, in silico docking, and molecular dynamics simulations to explore new anticancer agents. The innovation in this research lies in its multi-faceted approach, targeting not just the synthesis of compounds but also analyzing their molecular interactions to optimize their efficacy as anticancer drugs.Her contributions to the discovery and development of new therapeutic agents extend beyond cancer treatment. While working at Dr. Reddy’s, Archana played a crucial role in the R&D sector, contributing to key projects that focused on metabolic disorders like Type-II Diabetes. Her experience with leading pharmaceutical companies and her academic background allows her to bring a comprehensive perspective to the challenges in drug discovery.

Innovations in Pharmaceutical Sciences 💡

Archana has consistently leveraged cutting-edge technology in her research, particularly in the integration of computational methods with experimental data. Her use of in silico techniques for drug discovery, including molecular docking and simulations, has streamlined the identification of promising drug candidates, saving both time and resources. By combining computational approaches with traditional experimental methods, Archana’s research has opened new avenues for discovering efficient and targeted therapeutic solutions.Her innovative methodologies reflect her forward-thinking approach and her drive to push the boundaries of pharmaceutical research. This integration of technology into drug discovery processes ensures that her work not only meets current scientific standards but also sets the stage for future advancements in the field.

Accolades and Recognition 🏆

Throughout her career, Archana Kapoor has been recognized for her exceptional contributions to pharmaceutical sciences. She has been the recipient of several awards and honors, including a prestigious Award of Honour for her exemplary efforts in education and research. Her research publications in renowned scientific journals and her presentations at international conferences have further solidified her standing as a leader in her field.Her work has also earned her recognition within the scientific community for her research on novel anticancer agents. The synthesis and analysis of new chemical compounds that can potentially contribute to cancer treatment has positioned her as an influential voice in pharmaceutical research. Additionally, her GATE scholarship during her postgraduate studies underscores her academic brilliance and commitment to excellence.

Impact and Influence 🌍

Archana Kapoor’s impact extends beyond her own research; she has become a mentor and a guide for the next generation of pharmaceutical scientists. As a professor, she has not only imparted knowledge but has also encouraged her students to engage in innovative thinking and research. Her leadership in various academic and research initiatives at Guru Jambheshwar University has led to the establishment of strong research networks and collaborations, fostering a culture of inquiry and innovation.Her participation in seminars, workshops, and conferences has further contributed to knowledge dissemination and professional networking. She has been instrumental in organizing academic events that bring together experts from various fields to discuss advancements in pharmaceutical sciences. Through these efforts, Archana has become a key figure in the pharmaceutical academic community, influencing both her peers and her students.

Legacy and Future Contributions 🌱

Looking ahead, Archana Kapoor is committed to continuing her research in drug discovery, with a specific focus on developing new therapeutic agents for cancer and metabolic diseases. Her interdisciplinary approach, combining chemistry, pharmacology, and computational methods, promises to drive future innovations in pharmaceutical research.In addition to her research contributions, Archana aims to continue her mentorship role, guiding young scientists and researchers in their academic and professional journeys. Her legacy is not only defined by her own research achievements but also by the impact she has had on shaping the future of pharmaceutical sciences through her students.

Citations

A total of 208 citations for his publications, demonstrating the impact and recognition of his research within the academic community.

  • Citations         208
  • h-index           8
  • i10-index        6

Notable Publications 

  • Exploration of N‐(6‐Indazolyl) Benzenesulfonamide Derivatives as Potential Antioxidants and Antimicrobial Agents: Integrating Synthesis, In Silico Docking, and Bioactivity
    Authors: M. Yadav, R. Rao, S. Kumar, A. Kapoor
    Journal: ChemistrySelect, Vol. 8 (45), 2023
  • Development of 2-Dimensional and 3-Dimensional QSAR Models of Indazole Derivatives as TTK Inhibitors Having Anticancer Potential
    Authors: A.K. Mithlesh Yadav, Balasubramanian Narasimhan
    Journal: Current Chemistry Letters, Vol. 13 (1), 2023
  • Hybrid Descriptors–Conjoint Indices: A Case Study on Imidazole-Thiourea Containing Glutaminyl Cyclase Inhibitors for Design of Novel Anti-Alzheimer’s Candidates
    Authors: K. Bagri, A. Kapoor, P. Kumar, A. Kumar
    Journal: SAR and QSAR in Environmental Research, Vol. 34 (5), 2023
  • Anti-Hyperglycemic Evaluation of 2,4-Thiazolidinedione and Rhodanine Derivatives
    Authors: A. Kapoor, N. Khare
    Journal: Der Pharma Chemica, Vol. 8 (12), 2016
  • A Review on the Drug Delivery Strategies for Parasitic Infections: Scope and Assertion
    Authors: M. Bhatia, S. Kumar, A. Kapoor, S. Lohan
    Journal: Drug Delivery Letters, Vol. 12 (2), 2022.

Bandana Behera | Pharmacology | Women Researcher Award

Posted on by ScienceFather

Assist Prof Dr. Bandana Behera - Pharmacology - Women Researcher Award 🏆 

C.V Raman Global University - India

Professional Profiles

Early Academic Pursuits

Her academic journey began with a passion for pharmacology, culminating in her attainment of a Ph.D. in Pharmacy from Utkal University in 2022. Prior to this, she completed her post-graduation in Pharmacology with an outstanding score of 76.2% from Utkal University in 2016. Her academic excellence was evident even during her undergraduate studies, where she achieved an impressive CGPA of 8.76 in Bachelor of Pharmacy from BPUT in 2014.

Professional Endeavors

Her professional career has been marked by a blend of teaching, research, and academic contributions. With three years of experience in teaching and research at UDPS, Utkal University, serving as a Junior Research Fellow (JRF) and Senior Research Fellow (SRF), she has honed her skills in both theoretical and practical aspects of pharmacology. Additionally, she has two years of teaching and academic experience at prestigious institutions like BIT-Hyderabad and RCPHS-Brahmapur, Odisha.

Contributions and Research Focus in Pharmacology

Her research endeavors have focused on various aspects of pharmacology, with a particular emphasis on cancer research. Her expertise spans basic cell and molecular biology techniques, including cell cultures, Western blotting, cytometry, RT-qPCR, cloning, and immunofluorescence staining. She has also delved into in vivo experiments in mice, exploring animal models of traumatic brain injury (TBI) and middle cerebral artery occlusion (MCAO). Her research interests extend to immunopharmacology, nano-medicine, and molecular cloning/docking, demonstrating a diverse and multifaceted approach to pharmacological research.

Pharmacology is the branch of medicine and biology concerned with the study of drugs and their effects on living organisms. It encompasses various aspects of drug action, including pharmacokinetics (the absorption, distribution, metabolism, and excretion of drugs) and pharmacodynamics (the study of how drugs interact with their targets to produce therapeutic or toxic effects).

Accolades and Recognition

Her contributions to pharmacological research have been acknowledged through various accolades and recognition. Notably, she has been granted two patents and has applied for one patent, showcasing her innovative research contributions. Additionally, she has published 17 research papers, participated in multiple workshops, and presented her work at numerous conferences and poster presentations. Her book publications and participation in AICTE FDA programs further underscore her commitment to advancing pharmaceutical sciences.

Impact and Influence

Through her extensive research and academic endeavors, she has made a significant impact on the field of pharmacology. Her research outputs, including patents, publications, and presentations, have contributed to the body of knowledge in cancer research, immunopharmacology, and nano-medicine. Furthermore, her expertise in various laboratory techniques and methodologies has influenced the research practices of her peers and students, fostering a culture of excellence and innovation in pharmacological research.

Legacy and Future Contributions

Her legacy in pharmacology is characterized by her dedication to advancing knowledge and innovation in the field. Moving forward, she aims to continue her research pursuits, exploring new avenues in cancer research, immunopharmacology, and nano-medicine. Through her mentorship and leadership, she seeks to inspire the next generation of pharmacologists and contribute to the development of novel therapies and interventions for improving healthcare outcomes.

Citations

  • Citations               23
  • h-index                  3

Notable Publications